The citicoline brain injury treatment (COBRIT) trial: design and methods.
暂无分享,去创建一个
Ross Zafonte | Bruce Levin | Ramon Diaz-Arrastia | Shing M. Lee | B. Levin | H. Eisenberg | B. Ansel | R. Zafonte | T. Novack | N. Temkin | W. Friedewald | J. Ricker | J. Jallo | R. Diaz-Arrastia | S. Timmons | Nancy Temkin | Shelly D Timmons | Jack Jallo | Joseph Ricker | William T Friedewald | Shing M Lee | Beth Ansel | Howard Eisenberg | Thomas Novack | Randall Merchant | Randall E. Merchant
[1] Ramon Diaz-Arrastia,et al. Measuring Outcome in Traumatic Brain Injury Treatment Trials: Recommendations From the Traumatic Brain Injury Clinical Trials Network , 2010, The Journal of head trauma rehabilitation.
[2] G. Grieco,et al. Reply to the Letter by Derendorf: Clinical Trials and Dipyridamole Formulation Selection , 2006, Cerebrovascular Diseases.
[3] R. M. Adibhatla,et al. CDP-choline Significantly Restores Phosphatidylcholine Levels by Differentially Affecting Phospholipase A2 and CTP: Phosphocholine Cytidylyltransferase after Stroke* , 2006, Journal of Biological Chemistry.
[4] M. Fioravanti,et al. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. , 2005, The Cochrane database of systematic reviews.
[5] J. Langlois,et al. Can traumatic brain injury surveillance systems be used to link individuals with TBI to services? , 2004, Brain injury.
[6] R. Zafonte,et al. Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma. , 2004, Journal of neurotrauma.
[7] I. Ferrer,et al. Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells , 2003, Journal of the Neurological Sciences.
[8] S. Starkman,et al. Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke , 2003, Current treatment options in neurology.
[9] R. Dempsey,et al. Cytidinediphosphocholine treatment to decrease traumatic brain injury-induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats. , 2003, Journal of neurosurgery.
[10] S. Warach,et al. Oral Citicoline in Acute Ischemic Stroke: An Individual Patient Data Pooling Analysis of Clinical Trials , 2002, Stroke.
[11] R. M. Adibhatla,et al. Citicoline mechanisms and clinical efficacy in cerebral ischemia , 2002, Journal of neuroscience research.
[12] M. Rubio‐Stipec,et al. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. , 2002, Addiction.
[13] J. Baños,et al. California Verbal Learning Test-Second Edition , 2002 .
[14] R. Rejdak,et al. Citicoline Treatment Increases Retinal Dopamine Content in Rabbits , 2002, Ophthalmic Research.
[15] P. Renshaw,et al. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study , 2002, Psychopharmacology.
[16] L. Wechsler,et al. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients , 2001, Neurology.
[17] R. Dempsey,et al. Effects of Citicoline on Phospholipid and Glutathione Levels in Transient Cerebral Ischemia , 2001, Stroke.
[18] D. Marion,et al. Tyrosine hydroxylase, but not dopamine beta-hydroxylase, is increased in rat frontal cortex after traumatic brain injury , 2001, Neuroreport.
[19] R. Dempsey,et al. Does CDP-choline modulate phospholipase activities after transient forebrain ischemia? , 2001, Brain Research.
[20] S. Kish,et al. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease , 2001, Neuroscience.
[21] N. Kahveci,et al. Ischemic Brain Injury Caused by Interrupted Versus Uninterrupted Occlusion in Hypotensive Rats with Subarachnoid Hemorrhage: Neuroprotective Effects of Citicoline , 2001, Archives of physiology and biochemistry.
[22] S. Warach,et al. Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imaging , 2000 .
[23] R. Dempsey,et al. Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury. , 2000, Journal of Neurosurgery.
[24] W. Clark,et al. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. , 1999, Stroke.
[25] K A Dunn,et al. Traumatic brain injury in the United States: A public health perspective. , 1999, The Journal of head trauma rehabilitation.
[26] G. Teasdale,et al. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. , 1998, Journal of neurotrauma.
[27] S. Warach,et al. A randomized dose-response trial of citicoline in acute ischemic stroke patients , 1997, Neurology.
[28] T. Babor,et al. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). , 1997, Alcoholism, clinical and experimental research.
[29] D. Marion,et al. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. , 1997, Journal of neurotrauma.
[30] R Little,et al. Intent-to-treat analysis for longitudinal studies with drop-outs. , 1996, Biometrics.
[31] N L Geller,et al. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. , 1996, Stroke.
[32] D I Tang,et al. On the design and analysis of randomized clinical trials with multiple endpoints. , 1993, Biometrics.
[33] J. Povlishock,et al. Cytochemical detection of superoxide in cerebral inflammation and ischemia in vivo. , 1992, The American journal of physiology.
[34] J. A. Escario,et al. Effects of CDP-choline on the recovery of patients with head injury , 1991, Journal of the Neurological Sciences.
[35] H. Levin. Treatment of postconcussional symptoms with CDP-choline , 1991, Journal of the Neurological Sciences.
[36] D. Long,et al. The Molecular Basis of Brain Injury and Brain Edema: The Role of Oxygen Free Radicals , 1990, Neurosurgery.
[37] D. Rubin. Multiple imputation for nonresponse in surveys , 1989 .
[38] M. Fujishima,et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. , 1988, Stroke.
[39] N L Geller,et al. The analysis of multiple endpoints in clinical trials. , 1987, Biometrics.
[40] R. Larsen,et al. The Satisfaction with Life Scale , 1985, Journal of personality assessment.
[41] P. O'Brien. Procedures for comparing samples with multiple endpoints. , 1984, Biometrics.
[42] A. Benton. Contributions to Neuropsychological Assessment: A Clinical Manual , 1983 .
[43] M Rappaport,et al. Disability rating scale for severe head trauma: coma to community. , 1982, Archives of physical medicine and rehabilitation.
[44] H S Levin,et al. The Galveston Orientation and Amnesia Test: A Practical Scale to Assess Cognition after Head Injury , 1979, The Journal of nervous and mental disease.
[45] C. Dodrill. A Neuropsychological Battery for Epilepsy , 1978, Epilepsia.
[46] S. Udenfriend. B. TYROSINE HYDROXYLASE , 1966 .
[47] E. P. Kennedy. The synthesis of cytidine diphosphate choline, cytidine diphosphate ethanolamine, and related compounds. , 1956, The Journal of biological chemistry.
[48] J. Saver. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. , 2008, Reviews in neurological diseases.
[49] J. J. Ryan,et al. Wechsler Adult Intelligence Scale-III , 2001 .
[50] J. Leon-Carrion,et al. The role of citicholine in neuropsychological training after traumatic brain injury. , 2000, NeuroRehabilitation.
[51] J. Pavia,et al. Effects of chronic administration of S-adenosyl-l-methionine on brain oxidative stress in rats , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.
[52] J. Secades,et al. CDP-choline: pharmacological and clinical review. , 1995, Methods and findings in experimental and clinical pharmacology.
[53] L. Derogatis,et al. Brief Symptom Inventory Bsi Administration Scoring And Procedures Manual >>>CLICK HERE<<< , 1993 .
[54] R. Reitan,et al. The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation , 1993 .
[55] R. Reitan. Trail Making Test: Manual for Administration and Scoring , 1992 .
[56] F. Cohadon,et al. [A precursor of phospholipids in the treatment of severe traumatic comas]. , 1982, Neuro-Chirurgie.